5TA8:
reference: Structure-based design and SAR development of 5,6-dihydroimidazolo[1,5-f]pteridine derivatives as novel Polo-like kinase-1 inhibitors., Kiryanov A, Natala S, Jones B, McBride C, Feher V, Lam B, Liu Y, Honda K, Uchiyama N, Kawamoto T, Hikichi Y, Zhang L, Hosfield D, Skene R, Zou H, Stafford J, Cao X, Ichikawa T, Bioorg Med Chem Lett. 2017 Mar 1;27(5):1311-1315. doi:, 10.1016/j.bmcl.2016.10.009. Epub 2016 Oct 15. PMID: 28169164

This OCA Structure page
uses Jmol, developed by the Jmol Development Team (documentation).